Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Axl-Targeted Delivery of the Oncosuppressor miR-137 in Non-small-Cell Lung Cancer.

Nuzzo S, Catuogno S, Capuozzo M, Fiorelli A, Swiderski P, Boccella S, de Nigris F, Esposito CL.

Mol Ther Nucleic Acids. 2019 Jun 13;17:256-263. doi: 10.1016/j.omtn.2019.06.002. [Epub ahead of print]

2.

Targeted Delivery of miRNA Antagonists to Myeloid Cells In Vitro and In Vivo.

Su YL, Swiderski P, Marcucci G, Kortylewski M.

Methods Mol Biol. 2019;1974:141-150. doi: 10.1007/978-1-4939-9220-1_10.

PMID:
31099000
3.

Suicidal Carbon Monoxide Poisoning Using Motor Vehicle Exhaust in an Open Space.

Żaba C, Świderski P, Sommerfeld-Klatta K, Żaba Z, Pluta-Hadas K, Urbaniak M.

Med Princ Pract. 2019 Apr 16. doi: 10.1159/000500009. [Epub ahead of print]

4.

STAT3 Inhibition Combined with CpG Immunostimulation Activates Antitumor Immunity to Eradicate Genetically Distinct Castration-Resistant Prostate Cancers.

Moreira D, Adamus T, Zhao X, Su YL, Zhang Z, White SV, Swiderski P, Lu X, DePinho RA, Pal SK, Kortylewski M.

Clin Cancer Res. 2018 Dec 1;24(23):5948-5962. doi: 10.1158/1078-0432.CCR-18-1277. Epub 2018 Oct 18.

PMID:
30337279
5.

AptaBlocks: Designing RNA complexes and accelerating RNA-based drug delivery systems.

Wang Y, Hoinka J, Liang Y, Adamus T, Swiderski P, Przytycka TM.

Nucleic Acids Res. 2018 Sep 19;46(16):8133-8142. doi: 10.1093/nar/gky577.

6.

Bone marrow niche trafficking of miR-126 controls the self-renewal of leukemia stem cells in chronic myelogenous leukemia.

Zhang B, Nguyen LXT, Li L, Zhao D, Kumar B, Wu H, Lin A, Pellicano F, Hopcroft L, Su YL, Copland M, Holyoake TL, Kuo CJ, Bhatia R, Snyder DS, Ali H, Stein AS, Brewer C, Wang H, McDonald T, Swiderski P, Troadec E, Chen CC, Dorrance A, Pullarkat V, Yuan YC, Perrotti D, Carlesso N, Forman SJ, Kortylewski M, Kuo YH, Marcucci G.

Nat Med. 2018 May;24(4):450-462. doi: 10.1038/nm.4499. Epub 2018 Mar 5.

7.

B Cell Lymphoma Immunotherapy Using TLR9-Targeted Oligonucleotide STAT3 Inhibitors.

Zhao X, Zhang Z, Moreira D, Su YL, Won H, Adamus T, Dong Z, Liang Y, Yin HH, Swiderski P, Pillai RK, Kwak L, Forman S, Kortylewski M.

Mol Ther. 2018 Mar 7;26(3):695-707. doi: 10.1016/j.ymthe.2018.01.007. Epub 2018 Jan 17.

8.

Aptamer-Drug Conjugates of Active Metabolites of Nucleoside Analogs and Cytotoxic Agents Inhibit Pancreatic Tumor Cell Growth.

Yoon S, Huang KW, Reebye V, Spalding D, Przytycka TM, Wang Y, Swiderski P, Li L, Armstrong B, Reccia I, Zacharoulis D, Dimas K, Kusano T, Shively J, Habib N, Rossi JJ.

Mol Ther Nucleic Acids. 2017 Mar 17;6:80-88. doi: 10.1016/j.omtn.2016.11.008. Epub 2016 Dec 10.

9.

[Health state assessment in people sentenced to the penalty of restriction of liberty].

Świderski P, Żaba C, Macioszek N.

Med Pr. 2016 Dec 22;67(6):765-775. doi: 10.13075/mp.5893.00439. Epub 2016 Nov 22. Polish.

10.

Targeted Delivery of C/EBPα -saRNA by Pancreatic Ductal Adenocarcinoma-specific RNA Aptamers Inhibits Tumor Growth In Vivo.

Yoon S, Huang KW, Reebye V, Mintz P, Tien YW, Lai HS, Sætrom P, Reccia I, Swiderski P, Armstrong B, Jozwiak A, Spalding D, Jiao L, Habib N, Rossi JJ.

Mol Ther. 2016 Jun;24(6):1106-1116. doi: 10.1038/mt.2016.60. Epub 2016 Mar 17. Erratum in: Mol Ther. 2016 Dec;24(12):2131-2132.

11.

Serum-resistant CpG-STAT3 decoy for targeting survival and immune checkpoint signaling in acute myeloid leukemia.

Zhang Q, Hossain DM, Duttagupta P, Moreira D, Zhao X, Won H, Buettner R, Nechaev S, Majka M, Zhang B, Cai Q, Swiderski P, Kuo YH, Forman S, Marcucci G, Kortylewski M.

Blood. 2016 Mar 31;127(13):1687-700. doi: 10.1182/blood-2015-08-665604. Epub 2016 Jan 21.

12.

Cross-kingdom inhibition of breast cancer growth by plant miR159.

Chin AR, Fong MY, Somlo G, Wu J, Swiderski P, Wu X, Wang SE.

Cell Res. 2016 Feb;26(2):217-28. doi: 10.1038/cr.2016.13. Epub 2016 Jan 22.

13.

TLR9-Targeted SiRNA Delivery In Vivo.

Hossain DM, Moreira D, Zhang Q, Nechaev S, Swiderski P, Kortylewski M.

Methods Mol Biol. 2016;1364:183-96. doi: 10.1007/978-1-4939-3112-5_15.

14.

CTLA4 aptamer delivers STAT3 siRNA to tumor-associated and malignant T cells.

Herrmann A, Priceman SJ, Swiderski P, Kujawski M, Xin H, Cherryholmes GA, Zhang W, Zhang C, Lahtz C, Kowolik C, Forman SJ, Kortylewski M, Yu H.

J Clin Invest. 2015 Jun;125(6):2547. doi: 10.1172/JCI82555. Epub 2015 Jun 1. No abstract available.

15.

Application of X-rays to dental age estimation in medico-legal practice.

Lorkiewicz-Muszyńska D, Przystańska A, Kulczyk T, Hyrchała A, Bartecki B, Kociemba W, Glapiński M, Łabęcka M, Świderski P.

Arch Med Sadowej Kryminol. 2015;65(1):1-16.

16.

Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis.

Fong MY, Zhou W, Liu L, Alontaga AY, Chandra M, Ashby J, Chow A, O'Connor ST, Li S, Chin AR, Somlo G, Palomares M, Li Z, Tremblay JR, Tsuyada A, Sun G, Reid MA, Wu X, Swiderski P, Ren X, Shi Y, Kong M, Zhong W, Chen Y, Wang SE.

Nat Cell Biol. 2015 Feb;17(2):183-94. doi: 10.1038/ncb3094. Epub 2015 Jan 26.

17.

TLR9 is critical for glioma stem cell maintenance and targeting.

Herrmann A, Cherryholmes G, Schroeder A, Phallen J, Alizadeh D, Xin H, Wang T, Lee H, Lahtz C, Swiderski P, Armstrong B, Kowolik C, Gallia GL, Lim M, Brown C, Badie B, Forman S, Kortylewski M, Jove R, Yu H.

Cancer Res. 2014 Sep 15;74(18):5218-28. doi: 10.1158/0008-5472.CAN-14-1151. Epub 2014 Jul 21.

18.

CTLA4 aptamer delivers STAT3 siRNA to tumor-associated and malignant T cells.

Herrmann A, Priceman SJ, Swiderski P, Kujawski M, Xin H, Cherryholmes GA, Zhang W, Zhang C, Lahtz C, Kowolik C, Forman SJ, Kortylewski M, Yu H.

J Clin Invest. 2014 Jul;124(7):2977-87. doi: 10.1172/JCI73174. Epub 2014 Jun 2. Erratum in: J Clin Invest. 2015 Jun;125(6):2547. Swiderski, Piotr [Added].

19.

Causes of problems in multidisciplinary bitemark analysis

Przystańska A, Lorkiewicz-Muszyńska D, Glapiński M, Swiderski P, Łabecka M, Zaba C.

Arch Med Sadowej Kryminol. 2013 Jul-Sep;63(3):220-5. Review. Polish.

PMID:
24672898
20.

Multifunctional aptamer-miRNA conjugates for targeted cancer therapy.

Esposito CL, Cerchia L, Catuogno S, De Vita G, Dassie JP, Santamaria G, Swiderski P, Condorelli G, Giangrande PH, de Franciscis V.

Mol Ther. 2014 Jun;22(6):1151-1163. doi: 10.1038/mt.2014.5. Epub 2014 Jan 20.

21.

Leukemia cell-targeted STAT3 silencing and TLR9 triggering generate systemic antitumor immunity.

Hossain DM, Dos Santos C, Zhang Q, Kozlowska A, Liu H, Gao C, Moreira D, Swiderski P, Jozwiak A, Kline J, Forman S, Bhatia R, Kuo YH, Kortylewski M.

Blood. 2014 Jan 2;123(1):15-25. doi: 10.1182/blood-2013-07-517987. Epub 2013 Oct 29.

22.

TLR9 signaling in the tumor microenvironment initiates cancer recurrence after radiotherapy.

Gao C, Kozlowska A, Nechaev S, Li H, Zhang Q, Hossain DM, Kowolik CM, Chu P, Swiderski P, Diamond DJ, Pal SK, Raubitschek A, Kortylewski M.

Cancer Res. 2013 Dec 15;73(24):7211-21. doi: 10.1158/0008-5472.CAN-13-1314. Epub 2013 Oct 23.

23.

Novel RNA oligonucleotide improves liver function and inhibits liver carcinogenesis in vivo.

Reebye V, Sætrom P, Mintz PJ, Huang KW, Swiderski P, Peng L, Liu C, Liu X, Lindkaer-Jensen S, Zacharoulis D, Kostomitsopoulos N, Kasahara N, Nicholls JP, Jiao LR, Pai M, Spalding DR, Mizandari M, Chikovani T, Emara MM, Haoudi A, Tomalia DA, Rossi JJ, Habib NA.

Hepatology. 2014 Jan;59(1):216-27. doi: 10.1002/hep.26669. Epub 2013 Dec 9.

24.

Intracellular processing of immunostimulatory CpG-siRNA: Toll-like receptor 9 facilitates siRNA dicing and endosomal escape.

Nechaev S, Gao C, Moreira D, Swiderski P, Jozwiak A, Kowolik CM, Zhou J, Armstrong B, Raubitschek A, Rossi JJ, Kortylewski M.

J Control Release. 2013 Sep 28;170(3):307-15. doi: 10.1016/j.jconrel.2013.06.007. Epub 2013 Jun 15.

25.

Dual functional BAFF receptor aptamers inhibit ligand-induced proliferation and deliver siRNAs to NHL cells.

Zhou J, Tiemann K, Chomchan P, Alluin J, Swiderski P, Burnett J, Zhang X, Forman S, Chen R, Rossi J.

Nucleic Acids Res. 2013 Apr;41(7):4266-83. doi: 10.1093/nar/gkt125. Epub 2013 Mar 6.

26.

TLR9-mediated siRNA delivery for targeting of normal and malignant human hematopoietic cells in vivo.

Zhang Q, Hossain DM, Nechaev S, Kozlowska A, Zhang W, Liu Y, Kowolik CM, Swiderski P, Rossi JJ, Forman S, Pal S, Bhatia R, Raubitschek A, Yu H, Kortylewski M.

Blood. 2013 Feb 21;121(8):1304-15. doi: 10.1182/blood-2012-07-442590. Epub 2013 Jan 3.

27.

Functional in vivo delivery of multiplexed anti-HIV-1 siRNAs via a chemically synthesized aptamer with a sticky bridge.

Zhou J, Neff CP, Swiderski P, Li H, Smith DD, Aboellail T, Remling-Mulder L, Akkina R, Rossi JJ.

Mol Ther. 2013 Jan;21(1):192-200. doi: 10.1038/mt.2012.226. Epub 2012 Nov 20.

28.

[Problem of exposure to direct danger of death or grave detriment to health of a child breast-fed by an alcohol-abusing mother in medico-legal opinions].

Swiderski P, Zaba C, Tezyk A, Wachowiak R.

Arch Med Sadowej Kryminol. 2011 Apr-Jun;61(2):188-95. Polish.

PMID:
22390134
29.

[Fatal injuries of organs situated in the neck caused by fastened seat belts].

Łabecka M, Zaba C, Lorkiewicz-Muszyńska D, Swiderski P, Mularski A, Kołowski J.

Arch Med Sadowej Kryminol. 2011 Apr-Jun;61(2):170-5. Polish.

PMID:
22390131
30.

Systemic administration of combinatorial dsiRNAs via nanoparticles efficiently suppresses HIV-1 infection in humanized mice.

Zhou J, Neff CP, Liu X, Zhang J, Li H, Smith DD, Swiderski P, Aboellail T, Huang Y, Du Q, Liang Z, Peng L, Akkina R, Rossi JJ.

Mol Ther. 2011 Dec;19(12):2228-38. doi: 10.1038/mt.2011.207. Epub 2011 Sep 27.

31.

Humanized Lewis-Y specific antibody based delivery of STAT3 siRNA.

Ma Y, Kowolik CM, Swiderski PM, Kortylewski M, Yu H, Horne DA, Jove R, Caballero OL, Simpson AJ, Lee FT, Pillay V, Scott AM.

ACS Chem Biol. 2011 Sep 16;6(9):962-70. doi: 10.1021/cb200176v. Epub 2011 Jul 26.

32.

An aptamer-siRNA chimera suppresses HIV-1 viral loads and protects from helper CD4(+) T cell decline in humanized mice.

Neff CP, Zhou J, Remling L, Kuruvilla J, Zhang J, Li H, Smith DD, Swiderski P, Rossi JJ, Akkina R.

Sci Transl Med. 2011 Jan 19;3(66):66ra6. doi: 10.1126/scitranslmed.3001581.

33.

[Identification of a murderer on the basis of a biting pattern on body of the victim].

Zaba C, Lorkiewicz-Muszyńska D, Glapiński M, Smoluch K, Swiderski P.

Arch Med Sadowej Kryminol. 2010 Jan-Mar;60(1):22-6. Polish.

PMID:
21180105
34.

[Diagnostic and organizational error in head injuries].

Zaba C, Zaba Z, Swiderski P, Lorkiewicz-Muszyíska D.

Arch Med Sadowej Kryminol. 2009 Jul-Sep;59(3):259-62. Polish.

PMID:
20441091
35.

[Deaths in the sobering station in Poznan].

Zaba C, Swiderski P, Zaba Z, Lorkiewicz-Muszyńska D.

Arch Med Sadowej Kryminol. 2009 Apr-Jun;59(2):112-7. Polish.

PMID:
20073260
36.

Stability of thioester intermediates in ubiquitin-like modifications.

Song J, Wang J, Jozwiak AA, Hu W, Swiderski PM, Chen Y.

Protein Sci. 2009 Dec;18(12):2492-9. doi: 10.1002/pro.254.

37.

In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responses.

Kortylewski M, Swiderski P, Herrmann A, Wang L, Kowolik C, Kujawski M, Lee H, Scuto A, Liu Y, Yang C, Deng J, Soifer HS, Raubitschek A, Forman S, Rossi JJ, Pardoll DM, Jove R, Yu H.

Nat Biotechnol. 2009 Oct;27(10):925-32. doi: 10.1038/nbt.1564. Epub 2009 Sep 13.

38.

Selection, characterization and application of new RNA HIV gp 120 aptamers for facile delivery of Dicer substrate siRNAs into HIV infected cells.

Zhou J, Swiderski P, Li H, Zhang J, Neff CP, Akkina R, Rossi JJ.

Nucleic Acids Res. 2009 May;37(9):3094-109. doi: 10.1093/nar/gkp185. Epub 2009 Mar 21.

39.

Effects of cholesterol-tagged small interfering RNAs targeting 12/15-lipoxygenase on parameters of diabetic nephropathy in a mouse model of type 1 diabetes.

Yuan H, Lanting L, Xu ZG, Li SL, Swiderski P, Putta S, Jonnalagadda M, Kato M, Natarajan R.

Am J Physiol Renal Physiol. 2008 Aug;295(2):F605-17. doi: 10.1152/ajprenal.90268.2008. Epub 2008 Jun 18.

40.

Proinflammatory effects of advanced lipoxidation end products in monocytes.

Shanmugam N, Figarola JL, Li Y, Swiderski PM, Rahbar S, Natarajan R.

Diabetes. 2008 Apr;57(4):879-88. Epub 2007 Nov 14.

41.

[Consent of Jehovah's Witnesses to treatment with blood preparations: legal and ethical aspects].

Zaba C, Swiderski P, Zaba Z, Klimberg A, Przybylski Z.

Arch Med Sadowej Kryminol. 2007 Jan-Mar;57(1):138-43. Polish.

PMID:
17571519
42.

[Medico-legal problems of providing first aid].

Zaba C, Zaba Z, Orłowski M, Klimberg A, Swiderski P.

Arch Med Sadowej Kryminol. 2007 Jan-Mar;57(1):128-33. Polish.

PMID:
17571517
43.

[Treatment based on patient's consent: controversies, doubts, ambiguities].

Zaba C, Swiderski P, Zaba Z, Klimberg A, Przybylski Z.

Arch Med Sadowej Kryminol. 2007 Jan-Mar;57(1):122-7. Polish.

PMID:
17571516
44.

[Diagnosis of HIV infections in legal regulations].

Zaba C, Zaba Z, Klimberg A, Swiderski P.

Arch Med Sadowej Kryminol. 2007 Jan-Mar;57(1):118-21. Polish.

PMID:
17571515
45.

[Diagnostic errors in head injuries].

Zaba C, Zaba Z, Swiderski P, Klimberg A, Marcinkowski JT, Przybylskil Z.

Arch Med Sadowej Kryminol. 2007 Jan-Mar;57(1):115-7. Polish.

PMID:
17571514
46.

Construction of ordered protein arrays.

Clark J, Shevchuk T, Swiderski PM, Dabur R, Crocitto LE, Buryanov YI, Smith SS.

Methods Mol Biol. 2005;300:325-48. Review.

PMID:
15657490
47.

Mobility-shift analysis with microfluidics chips.

Clark J, Shevchuk T, Swiderski PM, Dabur R, Crocitto LE, Buryanov YI, Smith SS.

Biotechniques. 2003 Sep;35(3):548-54.

48.

Truncated amplification: a method for high-fidelity template-driven nucleic acid amplification.

Liu Q, Swiderski P, Sommer SS.

Biotechniques. 2002 Jul;33(1):129-32, 134-6, 138.

49.

Processing of UV damage in vitro by FEN-1 proteins as part of an alternative DNA excision repair pathway.

Yoon JH, Swiderski PM, Kaplan BE, Takao M, Yasui A, Shen B, Pfeifer GP.

Biochemistry. 1999 Apr 13;38(15):4809-17.

PMID:
10200169
50.

Delivery of an anti-HIV-1 ribozyme into HIV-infected cells via cationic liposomes.

Konopka K, Rossi JJ, Swiderski P, Slepushkin VA, Düzgüneş N.

Biochim Biophys Acta. 1998 Jun 24;1372(1):55-68.

Supplemental Content

Loading ...
Support Center